B. Vonbank

Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

M. Castanheira, P. Thuras, James R. Johnson, 2020, Antimicrobial Agents and Chemotherapy.

Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March–June 2020

R. Lynfield, R. Danila, K. Ehresmann, 2021, Emerging infectious diseases.

Utilization of Whole Genome Sequencing to Understand SARS-CoV-2 Transmission Dynamics in Long-Term Care Facilities, Correctional Facilities and Meat Processing Plants in Minnesota, March - June 2020

R. Lynfield, R. Danila, K. Ehresmann, 2021, medRxiv.

Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.

M. Castanheira, P. Thuras, James R. Johnson, 2021, The Journal of antimicrobial chemotherapy.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17.

W. Schaffner, B. Jackson, J. Nadle, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region

M. Castanheira, P. Thuras, James R. Johnson, 2020, Antimicrobial Agents and Chemotherapy.

363. National Burden of Candidemia, United States, 2017

W. Schaffner, S. Magill, G. Dumyati, 2018, Open Forum Infectious Diseases.

Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002-2017).

J. R. Johnson, M. Castanheira, P. Thuras, 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017

R. Lynfield, W. Bamberg, G. Dumyati, 2019, Open Forum Infectious Diseases.

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia

W. Schaffner, B. Jackson, G. Dumyati, 2018, Open Forum Infectious Diseases.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017

J. Nadle, B. Tesini, S. Vallabhaneni, 2020 .